Core Points - DiagnaMed Holdings Corp. is arranging a private placement of units with a minimum of $350,000 and a maximum of $510,000 at a price of $0.03 per unit [1][2] - Each unit consists of one common share and one common share purchase warrant, allowing the holder to acquire an additional common share at $0.05 for 24 months [2] - The net proceeds from the offering will be used for research, development, and commercialization of hydrogen production technology and the BRAIN AGE® Brain Health AI Platform [4] Offering Details - The offering may include finder's fees of up to 8% of gross proceeds and non-transferable finder warrants [5] - Up to 17,000,000 units may be issued under the Listed Issuer Financing Exemption, with no resale restrictions [6] - The anticipated closing date for the offering is on or about March 31, 2025, subject to regulatory approvals [7] Company Overview - DiagnaMed Holdings Corp. focuses on innovative technology solutions in the cleantech and life sciences sectors, particularly in hydrogen production and AI-driven drug discovery [8]

Core Viewpoint - American Tungsten Corp. is proceeding with a non-brokered private placement to raise $2,000,000 through the sale of 1,250,000 common shares at a price of $1.60 per share [1][4]. Group 1: Offering Details - The private placement is conducted under the Listed Issuer Financing Exemption, allowing it to be offered to purchasers in all Canadian provinces except Quebec [2]. - The securities offered will not be subject to a hold period under Canadian securities laws [2]. - The offering may close in one or more tranches and is contingent upon raising a minimum of $2,000,000 in gross proceeds [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for property payments, property exploration, marketing, and general working capital [3]. Group 3: Finder's Fees - The company will pay finders' fees of up to 7.0% of the gross proceeds raised and issue non-transferable finders' warrants equivalent to 7.0% of the number of shares sold [5]. Group 4: Company Background - American Tungsten Corp. is involved in the acquisition and exploration of mineral properties, including the Star Project in British Columbia and the IMA Mine Project in Idaho [7].

Core Viewpoint - Globe Life Inc. reported strong financial performance for the fourth quarter and full year of 2024, with increases in both net income and net operating income per diluted common share compared to the previous year [1][2]. Financial Performance - For Q4 2024, net income was $3.01 per diluted common share, up from $2.88 in Q4 2023, representing a 4.5% increase [1] - Net operating income for Q4 2024 was $3.14 per diluted common share, compared to $2.80 in Q4 2023, marking a 12% increase [1][8] - For the full year 2024, net income was $11.94 per diluted common share, an increase of 18.5% from $10.07 in 2023 [2] - Net operating income for the year was $12.37 per diluted common share, up 16.1% from $10.65 in 2023 [2] Insurance Operations - Life insurance accounted for 79% of the company's insurance underwriting margin for Q4 2024, while health insurance accounted for 21% [15] - Total premium revenue for Q4 2024 was $1.18 billion, a 4.5% increase from $1.13 billion in Q4 2023 [17] - Life insurance premiums increased by 4% to $822.96 million, and health insurance premiums rose by 7% to $358.31 million compared to the previous year [17] Investment Performance - Net investment income grew by 4% year-over-year, reaching $282.45 million in Q4 2024 [29] - Excess investment income for Q4 2024 was $38.33 million, a 7% increase from $35.82 million in Q4 2023 [29] - The investment portfolio's fixed maturities at fair value totaled $17.16 billion, representing 88% of the total investment portfolio [31] Share Repurchase and Capital Management - The company repurchased 337,821 shares of common stock during Q4 2024 at an average price of $105.37, totaling $36 million [37] - For the full year 2024, Globe Life repurchased 10.1 million shares at a total cost of $946 million [37] Future Guidance - Globe Life projects net operating income between $13.45 to $14.05 per diluted common share for the year ending December 31, 2025 [39]

Core Points - Trilogy AI Corp. has successfully closed a non-brokered private placement financing, raising approximately C$477,866.69 by issuing 6,826,667 common shares at C$0.07 each [1] - The company also completed a concurrent private placement, generating approximately C$362,196.82 from the sale of 5,174,240 common shares at the same price [1] - Additionally, Trilogy AI issued 9,311,500 warrants at C$0.05 each, raising gross proceeds of approximately C$465,575, with each warrant allowing the purchase of one common share for a period of 24 months [1] - The proceeds from these offerings will be utilized for working capital and general corporate purposes [3] Regulatory Information - The common shares from the LIFE Offering are exempt from a hold period under Canadian securities laws, while the private placement shares and warrants are subject to a statutory hold period of 4 months and one day [2] - The securities issued are not registered under the U.S. Securities Act and cannot be offered or sold in the United States without proper registration or exemption [4] Company Overview - Trilogy AI Corp. is focused on transforming the beauty industry through its AI beauty technology known as "Scarlett" [5]

Core Insights - IDEX Biometrics is entering the Japanese market in collaboration with LIFE CARD, introducing biometric payment cards, with commercial deployment expected in the first half of 2025 [1][2]. Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity, focusing on card-based applications [6]. - LIFE CARD, established in 1952, is a prominent credit card issuer in Japan, known for its innovative advancements in the credit system and commitment to financial inclusivity [7][8]. Market Context - Japan is a significant payment market in Asia, with over 314 million credit cards issued, accounting for more than 80% of cashless transactions, indicating a strong acceptance of digital payment methods [2]. - The introduction of biometric payment cards is expected to enhance security and convenience, aligning with Japan's reputation for technological innovation in payments [5]. Strategic Implications - The partnership between IDEX Biometrics and LIFE CARD aims to differentiate LIFE CARD's offerings in the competitive credit card market, potentially increasing customer acquisition and transaction volumes [3][4]. - The integration of biometric technology is anticipated to reinforce LIFE CARD's market positioning and enhance customer lifetime value [4].

Core Points - Edge Total Intelligence Inc. has successfully closed a non-brokered private placement offering, raising C$4,999,490 by issuing 9,433,000 units at a price of C$0.53 per unit [1][3] - Each unit consists of one subordinate voting share and one half of a purchase warrant, with the warrants exercisable at C$0.67 for 24 months [2] - The financing was fully subscribed by strategic long-term investors, including leading single-family investment firms in Canada [3] Financial Details - The offering generated gross proceeds of C$4,999,490, which will be utilized for sales and growth programs related to the company's Digital Twins technology, as well as general working capital [1][6] - The company paid a total of C$25,962.50 in cash finders' fees and C$125,000 to Roth Canada for financial advisory services [4] Regulatory Compliance - The offering was conducted under the listed issuer financing exemption, allowing units to be sold to purchasers in Canadian provinces (excluding Quebec) without a hold period [5] - The offering is subject to final approval from the TSX Venture Exchange [7] Company Overview - Edge Total Intelligence Inc. specializes in real-time digital operations software, particularly its edgeCore™ Digital Twin platform, which integrates multiple software applications and data sources [8] - The platform aims to enhance situational awareness and operational agility for global enterprises, service providers, and governments [8]

Core Points - Edge Total Intelligence Inc. announced a non-brokered private placement financing of up to 9,433,000 units at a price of C$0.53 per unit, aiming for gross proceeds of approximately C$4,999,490 [1] - Each unit consists of one subordinate voting share and one half of a purchase warrant, with the warrant exercisable at C$0.67 for 24 months, subject to an acceleration condition [1] - The net proceeds will be used for sales and growth programs related to the company's "Digital Twins" technology and for general working capital [4] Offering Details - The offering will be available to purchasers in Canadian provinces (excluding Quebec) under the Listed Issuer Financing Exemption, with no hold period for the securities issued [2] - The closing of the offering is contingent upon receiving necessary approvals and submitting required forms to the TSX Venture Exchange [5] Advisory Agreement - The company has entered into a financial advisory agreement with Roth Canada, Inc., which will provide strategic advisory services for a cash fee of $125,000 [7] Company Overview - Edge Total Intelligence Inc. specializes in real-time digital operations software, helping customers enhance situational awareness and accelerate actions through its edgeCore™ platform, which integrates multiple software applications and data sources into a "Digital Twin" experience [8]

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence Assessments of ALLEVYN LIFE Sacrum Foam Dressings and the LEAF Patient Monitoring System. In their latest reports, ECRI upgraded its Evidence Bar ratings for both to favorable* after assessing the most recently published clinical evidence and key outcomes for pressure injury prevention. The ECRI Evidence Bar pro ...

Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - Trilogy AI Corp. (formerly, Ambari Brands Inc.) (CSE: TRAI) (OTCQB: TRAIF) (FSE: Y920) (the "Company") is pleased to announce (i) a non-brokered private placement offering of up to 7,000,000 common shares in the authorized share structure of the Company ("Common Shares") at a price of C$0.07 per Common Share, for aggregate proceeds of up to C$490,000 (the "LIFE Offering"), and (ii) an additional (non-LIFE) private placement (the "Private P ...

From an On-Field Wedding to Broadcasting From the World's Largest Bowl of Cheez-It Crackers – Fans Will to Live Out their Wildest College Football 'Fantaseez' with the Help of New CFO, Reality Star Kordell BeckhamCHICAGO, Dec. 2, 2024 /PRNewswire/ -- Bowl season is almost here, and the Cheez-It® Citrus Bowl is bringing more absurd experiences than ever before. College football fans have wild game day fantasies they can only dream about – like proposing on the jumbotron or delivering a halftime peptalk to th ...